APO Research
Talk to an analyst

APO RESEARCH · REPORT

New Drug for Alzheimer's Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global New Drug for Alzheimer's Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025196 pages

Choose your research edition.

Industry ResearchNew Drug for Alzheimer's Treatment Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal New Drug for Alzheimer's Treatment Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal New Drug for Alzheimer's Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal New Drug for Alzheimer's Treatment Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal New Drug for Alzheimer's Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global New Drug for Alzheimer's Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for New Drug for Alzheimer's Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for New Drug for Alzheimer's Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for New Drug for Alzheimer's Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for New Drug for Alzheimer's Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of New Drug for Alzheimer's Treatment include Simcere, Eisai, Johnson and Johnson, Green Valley, Roche, Eli Lilly, Biogen, AstraZeneca and Vivoryon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global New Drug for Alzheimer's Treatment market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of New Drug for Alzheimer's Treatment and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents New Drug for Alzheimer's Treatment sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the New Drug for Alzheimer's Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

New Drug for Alzheimer's Treatment Segment by Company

Simcere

Eisai

Johnson and Johnson

Green Valley

Roche

Eli Lilly

Biogen

AstraZeneca

Vivoryon

Neurimmune

New Drug for Alzheimer's Treatment Segment by Type

AChE Target

Aβ Target

BChE Target

Others

New Drug for Alzheimer's Treatment Segment by Application

Mild Cognitive Impairment Stage

Preclinical Stage

Dementia Stage

New Drug for Alzheimer's Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global New Drug for Alzheimer's Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of New Drug for Alzheimer's Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of New Drug for Alzheimer's Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the New Drug for Alzheimer's Treatment market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of New Drug for Alzheimer's Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of New Drug for Alzheimer's Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of New Drug for Alzheimer's Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. New Drug for Alzheimer's Treatment Industry Trends Table 2. New Drug for Alzheimer's Treatment Industry Drivers Table 3. New Drug for Alzheimer's Treatment Industry Opportunities and Challenges Table 4. New Drug for Alzheimer's Treatment Industry Restraints Table 5. Global New Drug for Alzheimer's Treatment Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global New Drug for Alzheimer's Treatment Revenue Market Share by Manufacturers (2021-2026) Table 7. Global New Drug for Alzheimer's Treatment Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global New Drug for Alzheimer's Treatment Sales Market Share by Manufacturers Table 9. Global New Drug for Alzheimer's Treatment Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global New Drug for Alzheimer's Treatment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global New Drug for Alzheimer's Treatment Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global New Drug for Alzheimer's Treatment Manufacturers, Product Type & Application Table 13. Global New Drug for Alzheimer's Treatment Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global New Drug for Alzheimer's Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of AChE Target Table 17. Major Manufacturers of Aβ Target Table 18. Major Manufacturers of BChE Target Table 19. Major Manufacturers of Others Table 20. Global New Drug for Alzheimer's Treatment Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global New Drug for Alzheimer's Treatment Sales by Type (2021-2026) & (K Units) Table 22. Global New Drug for Alzheimer's Treatment Sales by Type (2027-2032) & (K Units) Table 23. Global New Drug for Alzheimer's Treatment Sales Market Share by Type (2021-2026) Table 24. Global New Drug for Alzheimer's Treatment Sales Market Share by Type (2027-2032) Table 25. Global New Drug for Alzheimer's Treatment Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global New Drug for Alzheimer's Treatment Revenue by Type (2021-2026) & (K Units) Table 27. Global New Drug for Alzheimer's Treatment Revenue by Type (2027-2032) & (K Units) Table 28. Global New Drug for Alzheimer's Treatment Revenue Market Share by Type (2021-2026) Table 29. Global New Drug for Alzheimer's Treatment Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Mild Cognitive Impairment Stage Table 31. Major Manufacturers of Preclinical Stage Table 32. Major Manufacturers of Dementia Stage Table 33. Global New Drug for Alzheimer's Treatment Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global New Drug for Alzheimer's Treatment Sales by Application (2021-2026) & (K Units) Table 35. Global New Drug for Alzheimer's Treatment Sales by Application (2027-2032) & (K Units) Table 36. Global New Drug for Alzheimer's Treatment Sales Market Share by Application (2021-2026) Table 37. Global New Drug for Alzheimer's Treatment Sales Market Share by Application (2027-2032) Table 38. Global New Drug for Alzheimer's Treatment Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global New Drug for Alzheimer's Treatment Revenue by Application (2021-2026) & (K Units) Table 40. Global New Drug for Alzheimer's Treatment Revenue by Application (2027-2032) & (K Units) Table 41. Global New Drug for Alzheimer's Treatment Revenue Market Share by Application (2021-2026) Table 42. Global New Drug for Alzheimer's Treatment Revenue Market Share by Application (2027-2032) Table 43. Global New Drug for Alzheimer's Treatment Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global New Drug for Alzheimer's Treatment Sales by Region (2021-2026) & (K Units) Table 45. Global New Drug for Alzheimer's Treatment Sales Market Share by Region (2021-2026) Table 46. Global New Drug for Alzheimer's Treatment Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global New Drug for Alzheimer's Treatment Sales Forecasted Market Share by Region (2027-2032) Table 48. North America New Drug for Alzheimer's Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America New Drug for Alzheimer's Treatment Sales by Country (2021-2026) & (K Units) Table 50. North America New Drug for Alzheimer's Treatment Sales by Country (2027-2032) & (K Units) Table 51. Europe New Drug for Alzheimer's Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe New Drug for Alzheimer's Treatment Sales by Country (2021-2026) & (K Units) Table 53. Europe New Drug for Alzheimer's Treatment Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific New Drug for Alzheimer's Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific New Drug for Alzheimer's Treatment Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific New Drug for Alzheimer's Treatment Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa New Drug for Alzheimer's Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa New Drug for Alzheimer's Treatment Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa New Drug for Alzheimer's Treatment Sales by Country (2027-2032) & (K Units) Table 60. Global New Drug for Alzheimer's Treatment Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global New Drug for Alzheimer's Treatment Revenue by Region (2021-2026) & (US$ Million) Table 62. Global New Drug for Alzheimer's Treatment Revenue by Region (2027-2032) & (US$ Million) Table 63. Global New Drug for Alzheimer's Treatment Revenue Market Share by Region (2021-2026) Table 64. Global New Drug for Alzheimer's Treatment Revenue Market Share by Region (2027-2032) Table 65. Simcere Company Information Table 66. Simcere Business Overview Table 67. Simcere New Drug for Alzheimer's Treatment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Simcere New Drug for Alzheimer's Treatment Product Portfolio Table 69. Simcere Recent Development Table 70. Eisai Company Information Table 71. Eisai Business Overview Table 72. Eisai New Drug for Alzheimer's Treatment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Eisai New Drug for Alzheimer's Treatment Product Portfolio Table 74. Eisai Recent Development Table 75. Johnson and Johnson Company Information Table 76. Johnson and Johnson Business Overview Table 77. Johnson and Johnson New Drug for Alzheimer's Treatment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Johnson and Johnson New Drug for Alzheimer's Treatment Product Portfolio Table 79. Johnson and Johnson Recent Development Table 80. Green Valley Company Information Table 81. Green Valley Business Overview Table 82. Green Valley New Drug for Alzheimer's Treatment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Green Valley New Drug for Alzheimer's Treatment Product Portfolio Table 84. Green Valley Recent Development Table 85. Roche Company Information Table 86. Roche Business Overview Table 87. Roche New Drug for Alzheimer's Treatment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Roche New Drug for Alzheimer's Treatment Product Portfolio Table 89. Roche Recent Development Table 90. Eli Lilly Company Information Table 91. Eli Lilly Business Overview Table 92. Eli Lilly New Drug for Alzheimer's Treatment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Eli Lilly New Drug for Alzheimer's Treatment Product Portfolio Table 94. Eli Lilly Recent Development Table 95. Biogen Company Information Table 96. Biogen Business Overview Table 97. Biogen New Drug for Alzheimer's Treatment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Biogen New Drug for Alzheimer's Treatment Product Portfolio Table 99. Biogen Recent Development Table 100. AstraZeneca Company Information Table 101. AstraZeneca Business Overview Table 102. AstraZeneca New Drug for Alzheimer's Treatment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. AstraZeneca New Drug for Alzheimer's Treatment Product Portfolio Table 104. AstraZeneca Recent Development Table 105. Vivoryon Company Information Table 106. Vivoryon Business Overview Table 107. Vivoryon New Drug for Alzheimer's Treatment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Vivoryon New Drug for Alzheimer's Treatment Product Portfolio Table 109. Vivoryon Recent Development Table 110. Neurimmune Company Information Table 111. Neurimmune Business Overview Table 112. Neurimmune New Drug for Alzheimer's Treatment Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Neurimmune New Drug for Alzheimer's Treatment Product Portfolio Table 114. Neurimmune Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. New Drug for Alzheimer's Treatment Distributors List Table 118. New Drug for Alzheimer's Treatment Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. New Drug for Alzheimer's Treatment Product Image Figure 2. Global New Drug for Alzheimer's Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global New Drug for Alzheimer's Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global New Drug for Alzheimer's Treatment Sales (2021-2032) & (K Units) Figure 5. Global New Drug for Alzheimer's Treatment Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 New Drug for Alzheimer's Treatment Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. AChE Target Image Figure 9. Aβ Target Image Figure 10. BChE Target Image Figure 11. Others Image Figure 12. Global New Drug for Alzheimer's Treatment Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global New Drug for Alzheimer's Treatment Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global New Drug for Alzheimer's Treatment Sales Market Share by Type (2021-2032) Figure 15. Global New Drug for Alzheimer's Treatment Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global New Drug for Alzheimer's Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global New Drug for Alzheimer's Treatment Revenue Market Share by Type (2021-2032) Figure 18. Mild Cognitive Impairment Stage Image Figure 19. Preclinical Stage Image Figure 20. Dementia Stage Image Figure 21. Global New Drug for Alzheimer's Treatment Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global New Drug for Alzheimer's Treatment Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global New Drug for Alzheimer's Treatment Sales Market Share by Application (2021-2032) Figure 24. Global New Drug for Alzheimer's Treatment Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global New Drug for Alzheimer's Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global New Drug for Alzheimer's Treatment Revenue Market Share by Application (2021-2032) Figure 27. North America New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America New Drug for Alzheimer's Treatment Sales Market Share by Country (2021-2032) Figure 29. U.S. New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe New Drug for Alzheimer's Treatment Sales Market Share by Country (2021-2032) Figure 34. Germany New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific New Drug for Alzheimer's Treatment Sales Market Share by Country (2021-2032) Figure 41. China New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa New Drug for Alzheimer's Treatment Sales Market Share by Country (2021-2032) Figure 49. Brazil New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile New Drug for Alzheimer's Treatment Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global New Drug for Alzheimer's Treatment Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global New Drug for Alzheimer's Treatment Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America New Drug for Alzheimer's Treatment Revenue (2021-2032) & (US$ Million) Figure 60. North America New Drug for Alzheimer's Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe New Drug for Alzheimer's Treatment Revenue (2021-2032) & (US$ Million) Figure 62. Europe New Drug for Alzheimer's Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific New Drug for Alzheimer's Treatment Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific New Drug for Alzheimer's Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa New Drug for Alzheimer's Treatment Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa New Drug for Alzheimer's Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. New Drug for Alzheimer's Treatment Value Chain Figure 68. Manufacturing Cost Structure Figure 69. New Drug for Alzheimer's Treatment Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • AChE Target
  • Aβ Target
  • BChE Target
  • Others
Applications
  • Mild Cognitive Impairment Stage
  • Preclinical Stage
  • Dementia Stage
Companies covered
  • Simcere
  • Eisai
  • Johnson and Johnson
  • Green Valley
  • Roche
  • Eli Lilly
  • Biogen
  • AstraZeneca
  • Vivoryon
  • Neurimmune

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global New Drug for Alzheimer's Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global New Drug for Alzheimer's Treatment Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global New Drug for Alzheimer's Treatment Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global New Drug for Alzheimer's Treatment Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global New Drug for Alzheimer's Treatment Market Dynamics
  1. 2.1 New Drug for Alzheimer's Treatment Industry Trends
  2. 2.2 New Drug for Alzheimer's Treatment Industry Drivers
  3. 2.3 New Drug for Alzheimer's Treatment Industry Opportunities and Challenges
  4. 2.4 New Drug for Alzheimer's Treatment Industry Restraints
3 New Drug for Alzheimer's Treatment Market by Manufacturers
  1. 3.1 Global New Drug for Alzheimer's Treatment Revenue by Manufacturers (2021-2026)
  2. 3.2 Global New Drug for Alzheimer's Treatment Sales by Manufacturers (2021-2026)
  3. 3.3 Global New Drug for Alzheimer's Treatment Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global New Drug for Alzheimer's Treatment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global New Drug for Alzheimer's Treatment Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global New Drug for Alzheimer's Treatment Manufacturers, Product Type & Application
  7. 3.7 Global New Drug for Alzheimer's Treatment Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global New Drug for Alzheimer's Treatment Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 New Drug for Alzheimer's Treatment Players Market Share by Revenue in 2025
  11. 3.8.3 2025 New Drug for Alzheimer's Treatment Tier 1, Tier 2, and Tier 3
4 New Drug for Alzheimer's Treatment Market by Type
  1. 4.1 New Drug for Alzheimer's Treatment Type Introduction
  2. 4.1.1 AChE Target
  3. 4.1.2 Aβ Target
  4. 4.1.3 BChE Target
  5. 4.1.4 Others
  6. 4.2 Global New Drug for Alzheimer's Treatment Sales by Type
  7. 4.2.1 Global New Drug for Alzheimer's Treatment Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global New Drug for Alzheimer's Treatment Sales by Type (2021-2032)
  9. 4.2.3 Global New Drug for Alzheimer's Treatment Sales Market Share by Type (2021-2032)
  10. 4.3 Global New Drug for Alzheimer's Treatment Revenue by Type
  11. 4.3.1 Global New Drug for Alzheimer's Treatment Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global New Drug for Alzheimer's Treatment Revenue by Type (2021-2032)
  13. 4.3.3 Global New Drug for Alzheimer's Treatment Revenue Market Share by Type (2021-2032)
5 New Drug for Alzheimer's Treatment Market by Application
  1. 5.1 New Drug for Alzheimer's Treatment Application Introduction
  2. 5.1.1 Mild Cognitive Impairment Stage
  3. 5.1.2 Preclinical Stage
  4. 5.1.3 Dementia Stage
  5. 5.2 Global New Drug for Alzheimer's Treatment Sales by Application
  6. 5.2.1 Global New Drug for Alzheimer's Treatment Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global New Drug for Alzheimer's Treatment Sales by Application (2021-2032)
  8. 5.2.3 Global New Drug for Alzheimer's Treatment Sales Market Share by Application (2021-2032)
  9. 5.3 Global New Drug for Alzheimer's Treatment Revenue by Application
  10. 5.3.1 Global New Drug for Alzheimer's Treatment Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global New Drug for Alzheimer's Treatment Revenue by Application (2021-2032)
  12. 5.3.3 Global New Drug for Alzheimer's Treatment Revenue Market Share by Application (2021-2032)
6 Global New Drug for Alzheimer's Treatment Sales by Region
  1. 6.1 Global New Drug for Alzheimer's Treatment Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global New Drug for Alzheimer's Treatment Sales by Region (2021-2032)
  3. 6.2.1 Global New Drug for Alzheimer's Treatment Sales by Region (2021-2026)
  4. 6.2.2 Global New Drug for Alzheimer's Treatment Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America New Drug for Alzheimer's Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America New Drug for Alzheimer's Treatment Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe New Drug for Alzheimer's Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe New Drug for Alzheimer's Treatment Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific New Drug for Alzheimer's Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific New Drug for Alzheimer's Treatment Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa New Drug for Alzheimer's Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa New Drug for Alzheimer's Treatment Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global New Drug for Alzheimer's Treatment Revenue by Region
  1. 7.1 Global New Drug for Alzheimer's Treatment Revenue by Region
  2. 7.1.1 Global New Drug for Alzheimer's Treatment Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global New Drug for Alzheimer's Treatment Revenue by Region (2021-2026)
  4. 7.1.3 Global New Drug for Alzheimer's Treatment Revenue by Region (2027-2032)
  5. 7.1.4 Global New Drug for Alzheimer's Treatment Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America New Drug for Alzheimer's Treatment Revenue (2021-2032)
  8. 7.2.2 North America New Drug for Alzheimer's Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe New Drug for Alzheimer's Treatment Revenue (2021-2032)
  11. 7.3.2 Europe New Drug for Alzheimer's Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific New Drug for Alzheimer's Treatment Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific New Drug for Alzheimer's Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa New Drug for Alzheimer's Treatment Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa New Drug for Alzheimer's Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Simcere
  2. 8.1.1 Simcere Company Information
  3. 8.1.2 Simcere Business Overview
  4. 8.1.3 Simcere New Drug for Alzheimer's Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Simcere New Drug for Alzheimer's Treatment Product Portfolio
  6. 8.1.5 Simcere Recent Developments
  7. 8.2 Eisai
  8. 8.2.1 Eisai Company Information
  9. 8.2.2 Eisai Business Overview
  10. 8.2.3 Eisai New Drug for Alzheimer's Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eisai New Drug for Alzheimer's Treatment Product Portfolio
  12. 8.2.5 Eisai Recent Developments
  13. 8.3 Johnson and Johnson
  14. 8.3.1 Johnson and Johnson Company Information
  15. 8.3.2 Johnson and Johnson Business Overview
  16. 8.3.3 Johnson and Johnson New Drug for Alzheimer's Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson and Johnson New Drug for Alzheimer's Treatment Product Portfolio
  18. 8.3.5 Johnson and Johnson Recent Developments
  19. 8.4 Green Valley
  20. 8.4.1 Green Valley Company Information
  21. 8.4.2 Green Valley Business Overview
  22. 8.4.3 Green Valley New Drug for Alzheimer's Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Green Valley New Drug for Alzheimer's Treatment Product Portfolio
  24. 8.4.5 Green Valley Recent Developments
  25. 8.5 Roche
  26. 8.5.1 Roche Company Information
  27. 8.5.2 Roche Business Overview
  28. 8.5.3 Roche New Drug for Alzheimer's Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roche New Drug for Alzheimer's Treatment Product Portfolio
  30. 8.5.5 Roche Recent Developments
  31. 8.6 Eli Lilly
  32. 8.6.1 Eli Lilly Company Information
  33. 8.6.2 Eli Lilly Business Overview
  34. 8.6.3 Eli Lilly New Drug for Alzheimer's Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eli Lilly New Drug for Alzheimer's Treatment Product Portfolio
  36. 8.6.5 Eli Lilly Recent Developments
  37. 8.7 Biogen
  38. 8.7.1 Biogen Company Information
  39. 8.7.2 Biogen Business Overview
  40. 8.7.3 Biogen New Drug for Alzheimer's Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Biogen New Drug for Alzheimer's Treatment Product Portfolio
  42. 8.7.5 Biogen Recent Developments
  43. 8.8 AstraZeneca
  44. 8.8.1 AstraZeneca Company Information
  45. 8.8.2 AstraZeneca Business Overview
  46. 8.8.3 AstraZeneca New Drug for Alzheimer's Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AstraZeneca New Drug for Alzheimer's Treatment Product Portfolio
  48. 8.8.5 AstraZeneca Recent Developments
  49. 8.9 Vivoryon
  50. 8.9.1 Vivoryon Company Information
  51. 8.9.2 Vivoryon Business Overview
  52. 8.9.3 Vivoryon New Drug for Alzheimer's Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Vivoryon New Drug for Alzheimer's Treatment Product Portfolio
  54. 8.9.5 Vivoryon Recent Developments
  55. 8.10 Neurimmune
  56. 8.10.1 Neurimmune Company Information
  57. 8.10.2 Neurimmune Business Overview
  58. 8.10.3 Neurimmune New Drug for Alzheimer's Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Neurimmune New Drug for Alzheimer's Treatment Product Portfolio
  60. 8.10.5 Neurimmune Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 New Drug for Alzheimer's Treatment Value Chain Analysis
  2. 9.1.1 New Drug for Alzheimer's Treatment Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 New Drug for Alzheimer's Treatment Production Mode & Process
  6. 9.2 New Drug for Alzheimer's Treatment Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 New Drug for Alzheimer's Treatment Distributors
  9. 9.2.3 New Drug for Alzheimer's Treatment Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst